SCHEMBL6907522

SCHEMBL6907522

COc1ccc(OC)c(C(=O)C=Cc2ccc(O)cc2)c1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.89
XDH P47989 1/20 0.80
PDE4A P27815 1/20 0.78
PDE4B Q07343 1/20 0.78
PDE4C Q08493 1/20 0.78
PDE4D Q08499 1/20 0.78
MAPT P10636 5/20 0.69
MEN1 O00255 3/20 0.69
MAPK1 P28482 3/20 0.69
KMT2A Q03164 3/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
ALDH1A1 P00352 2/20 0.69
HPGD P15428 2/20 0.69
ALOX15 P16050 2/20 0.69
HSD17B10 Q99714 2/20 0.69
KDM4E B2RXH2 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
LMNA P02545 2/20 0.68
CYP3A4 P08684 2/20 0.68
CAPN1 P07384 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6907516 1.00 ABCG2 (0.89) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL633046 0.93 ABCG2 (0.97) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL633045 0.93 ABCG2 (0.97) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL21527708 0.89 XDH (1.00) ABCG2XDHMAPTMEN1MAPK1
SCHEMBL21527710 0.89 XDH (1.00) ABCG2XDHMAPTMEN1MAPK1
SCHEMBL19183195 0.88 ABCG2 (0.86) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL19183196 0.88 ABCG2 (0.86) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL31619678 0.88 ABCG2 (0.86) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL6902519 0.88 ABCG2 (0.86) ABCG2XDHPDE4APDE4BPDE4C
SCHEMBL6902513 0.88 ABCG2 (0.86) ABCG2XDHPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same PTGS1, PTGES2, PTGES ABCG2 71/4885XDH 1167/4885PDE4A 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.